Evidence map›Paper›PMID 41514220›Full record

Observational studyBMC infectious diseases2026

Hematological and biochemical markers for predicting severity in COVID-19 patients.

Abdulrahman H Amer, Hitesh Shah, Kaushik Chaudhari

Abstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abdulrahman H AmerDepartment of Laboratory Medicine, Faculty of Medical Sciences, Thamar University, Dhamar, Yemen. hefdhallaha@tu.edu.ye.ORCID http://orcid.org/0000-0001-5243-6816
Hitesh ShahDepartment of Biochemistry, Pramukhswami Medical College, and Shree Krishna Hospital, Bhaikaka University, Gokalnagar, Karamsad, Anand, Gujarat, 388325, India.
Kaushik ChaudhariDepartment of Biochemistry, Banas Medical College and Research Institute, Palanpur, Gujarat, 385001, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe early identification of patients at risk of severe coronavirus disease 2019 (COVID-19) is a clinical priority. This study aimed to evaluate hematological and inflammatory biomarkers between mild and severe cases of COVID-19 in an Indian cohort.

methodsA retrospective observational study was conducted on 240 RT-PCR-confirmed COVID-19 patients admitted to Shree Krishna Hospital, Gujarat, India. Patients were classified as severe (n = 170) or non-severe (n = 70) based on clinical criteria. Levels of interleukin-6 (IL-6), ferritin, D-dimer, C-reactive protein (CRP), lactate dehydrogenase (LDH), and hematological parameters were analyzed upon hospital admission. Data were analyzed using SPSS, version 24.0. The Shapiro-Wilk test assessed normality. The Mann-Whitney U test was used for non-normally distributed variables in group comparisons, while the independent samples t-test was used for normally distributed variables. Diagnostic performance was evaluated via Receiver Operating Characteristic (ROC) curve analysis, and associations with severe disease were examined using logistic regression.

resultsPatients with severe disease were significantly older (median 61.5 vs. 47 years, p < 0.001). Severe illness was demonstrated significant association with elevated inflammatory markers (IL-6, ferritin, LDH, CRP, D-dimer; all p < 0.001) and hematological dysregulation, notably neutrophilia, lymphocytopenia, and an elevated neutrophil-to-lymphocyte ratio (NLR) (all p < 0.001). ROC analysis identified LDH (AUC = 0.76), ferritin (AUC = 0.74), and NLR (AUC = 0.73) as the best discriminators, with optimal cut-offs of 319 U/L, 255 µg/L, and 4.3, respectively. In multivariate analysis adjusted for age and other biomarkers, only older age (adjusted OR: 1.03 per year; 95% CI: 1.00–1.05; p = 0.008) and elevated ferritin (adjusted OR: 1.44; 95% CI: 1.03–2.01; p = 0.03) maintained a statistically significant independent association with severe disease. The significant univariate associations for IL-6, LDH, and CRP were attenuated in the adjusted model.

conclusionAdmission levels of IL-6, NLR, ferritin, and LDH showed strong associations with COVID-19 severity and offered good discriminatory value for risk stratification. However, after accounting for key confounders, older age and hyperferritinemia were the factors most robustly and independently associated with severe outcomes. These findings underscore the importance of multivariate evaluation to identify core prognostic factors and support the use of accessible biomarkers like ferritin and NLR in triage protocols.

Indexed as

BiomarkersCOVID-19AdultAgedC-Reactive ProteinFemaleFerritinsFibrin Fibrinogen Degradation ProductsHumansIndiaInterleukin-6L-Lactate DehydrogenaseMaleMiddle AgedPandemicsRetrospective StudiesBiomarkersC-Reactive ProteinFerritinsFibrin Fibrinogen Degradation Productsfibrin fragment DInterleukin-6L-Lactate DehydrogenaseAnd inflammationBiomarkersLymphopeniaPrognosisSeverity of COVID-19

Identifiers

PMID41514220
PMCPMC12882411

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.